# EDGAR Filing Document

**Accession Number:** 0001401708
**File Stem:** 0001401708-23-000069
**Filing Date:** 2023-3
**Character Count:** 8565
**Document Hash:** 219a5d64aa637382c88840a65bd16662
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001401708-23-000069.hdr.sgml**: 20230307

**ACCESSION NUMBER**: 0001401708-23-000069

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230304

**FILED AS OF DATE**: 20230307

**DATE AS OF CHANGE**: 20230307

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** GRAY R BRADLEY
- **CENTRAL INDEX KEY:** 0001575739

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35980
- **FILM NUMBER:** 23714348

**MAIL ADDRESS:**
- **STREET 1:** 530 FAIRVIEW AVENUE NORTH
- **STREET 2:** SUITE 2000
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98109
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NanoString Technologies Inc
- **CENTRAL INDEX KEY:** 0001401708
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 200094687
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 530 FAIRVIEW AVENUE NORTH
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98109
- **BUSINESS PHONE:** 206-378-6266

**MAIL ADDRESS:**
- **STREET 1:** 530 FAIRVIEW AVENUE NORTH
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98109

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>GRAY R BRADLEY<br><sub>(Last) (First) (Middle)</sub><br>530 FAIRVIEW AVENUE N<br><sub>(Street)</sub><br>SEATTLE, WA 98109<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-04 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President and CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>NanoString Technologies Inc [ NSTG ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-06 |  | M |  | 16463 | A | $0 | 294021 | D |  |
| Common Stock | 2023-03-06 |  | F<sup>(1)</sup> |  | 6479 | D | $10.16 | 287542 | D |  |
| Common Stock | 2023-03-06 |  | M |  | 8063 | A | $0 | 295605 | D |  |
| Common Stock | 2023-03-06 |  | F<sup>(1)</sup> |  | 3173 | D | $10.13 | 292432 | D |  |
| Common Stock | 2023-03-06 |  | M |  | 26320 | A | $0 | 318752 | D |  |
| Common Stock | 2023-03-06 |  | F<sup>(1)</sup> |  | 10357 | D | $10.16 | 308395 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(2)</sup> | 2023-03-04 |  | A |  | 354545 |  | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 354545.0 | $0 | 354545 | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2023-03-06 |  | M |  |  | 16463 | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 16463.0 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2023-03-06 |  | M |  |  | 8063 | <sup>(5)</sup> | <sup>(5)</sup> | Common Stock | 8063.0 | $0 | 8063 | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2023-03-06 |  | M |  |  | 26320 | <sup>(6)</sup> | <sup>(6)</sup> | Common Stock | 26320.0 | $0 | 52642 | D |  |

---

### Footnotes:

(1) The reported shares were withheld to cover the reporting person's tax liability in connection with the vesting of Restricted Stock Units ("RSUs"). The shares were not issued to or sold by the reporting person.

(2) Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.

(3) 1/3 of the RSUs vest on or following the first anniversary of March 5, 2023 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on or after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.

(4) 1/3 of the RSUs vest on the first market trading day following the first anniversary of March 5, 2020 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on the first market trading day on or after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.

(5) 1/3 of the RSUs vest on the first market trading day following the first anniversary of March 5, 2021 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on the first market trading day after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.

(6) 1/3 of the RSUs vest on or following the first market trading day following the first anniversary of March 5, 2022 (the "RSU Vesting Commencement Date"), and 1/3 of the RSUs vest annually each year on or following the first market trading day on or after the second and third anniversary of the RSU Vesting Commencement Date, in each case, subject to Participant's continuing to be a Service Provider (as defined in the 2013 Equity Incentive Plan) through each such date.

**Signature:** /s/ Shannon Atchison, Attorney in Fact  
**Date:** 2023-03-07

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**